中医学报2024，Vol.39Issue(1)：26-29,4.DOI:10.16368/j.issn.1674-8999.2024.01.005
从"诸湿肿满,皆属于脾"探讨射血分数保留的心力衰竭的辨治
Treatment of Heart Failure with Preserved Ejection Fraction Based on Concept of"All Swelling and Edema Relating to Spleen"
摘要
Abstract
The key pathogenesis of Heart failure with preserved ejection fraction is"all Dampness and swelling relating to Spleen".The Qi of the Five Zang are interconnected,and there are times when the Heart is affected by the disease Qi transmitted from the Spleen,that is,the child's disease is transmitted to the mother,and then to the Lungs that Heart conqueres,leaving the disease in the Liver that produces it,and finally to the Kidney that it cannot conquer.This is called"Spleen disease",which leads to"Heart disease".In the early stage of Heart failure with preserved ejection fraction,the diastolic function of the Heart decreases,leading to Spleen and Lung Qi deficiency and Phlegm Turbidity.The treatment should strengthen the Spleen and benefit the Lung,dispeling Phlegm and reducing swelling.It is optional to treat both the Lung and Spleen with Shenling Baizhu Powder.In the middle stage of the disease,as the conges-tion in the pulmonary circulation worsens,it leads to disharmony between the Liver and Spleen as well as the stagnation of blood stasis.The treatment should be based on regulating the Spleen and Liver,dispersing blood stasis and promoting blood circulation.The option is to use Sini Powder to regulate the Spleen and Liver.In the late stage of the disease,both pulmonary and systemic circulation with blood stasis leading to spleen and Kidney Yang deficiency and excessive Water.The treatment should be warming the Spleen and Kidney,namely,warming the Yang and transforming the Yin.Zhenwu Decoction can be used to achieve the purpose.关键词
射血分数保留的心力衰竭/"诸湿肿满,皆属于脾"/参苓白术散/四逆散/真武汤Key words
Heart failure with preserved ejection fraction/all dampness and swelling relating to Spleen/Shenling Baizhu Powder/Si Ni Powder/Zhenwu Decoction分类
医药卫生引用本文复制引用
贾思涵,李明轩,尚菊菊,刘红旭..从"诸湿肿满,皆属于脾"探讨射血分数保留的心力衰竭的辨治[J].中医学报,2024,39(1):26-29,4.基金项目
国家自然科学基金项目(81703850) （81703850）
